Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Share:
Related UNH
UnitedHealth Lower Off NYT Article Claiming Suit For Overbilling Medicare
Headline Risk Haunts PBMs As Drug Pricing Debate Intensifies
Stocks Close Higher; UnitedHealth Drags The Dow (Investor's Business Daily)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Latest Ratings for UNH

DateFirmActionFromTo
Feb 2017Cantor FitzgeraldInitiates Coverage OnOverweight
Jan 2017PiperJaffrayInitiates Coverage OnOverweight
Dec 2016Cantor FitzgeraldUpgradesHoldBuy

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (UNH)

View Comments and Join the Discussion!